Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

OBI Pharma, Inc. (4174) Income Statement

OBI Pharma, Inc. Income Statement

Last quarter (Q2 2026), OBI Pharma, Inc.'s total revenue was NT$15.28M, an increase of 19.77% from the same quarter last year. In Q2, OBI Pharma, Inc.'s net income was NT$-197.55M. See OBI Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Mar 24Dec 22Dec 21
NT$ 58.58MNT$ 62.68MNT$ 41.55MNT$ 4.71MNT$ 18.77M
NT$ -77.53MNT$ -76.27MNT$ -73.50MNT$ -40.14MNT$ -25.59M
NT$ 2.09BNT$ 2.30BNT$ 2.02BNT$ 2.08BNT$ 1.69B
Depreciation and AmortizationNT$ 227.16MNT$ 222.25MNT$ 248.95MNT$ 246.61MNT$ 216.28M
NT$ -1.94BNT$ -2.26BNT$ -1.02BNT$ -1.67BNT$ -1.52B
NT$ -2.17BNT$ -2.37BNT$ -2.09BNT$ -1.91BNT$ -1.74B
NT$ -90.69MNT$ -124.68MNT$ 814.24MNT$ 205.67MNT$ -26.24M
NT$ -2.26BNT$ -2.50BNT$ -1.28BNT$ -1.92BNT$ -1.74B
NT$ -2.05BNT$ -2.31BNT$ -1.05BNT$ -1.90BNT$ -1.72B
Per Share Metrics
Basic EPSNT$ -31.22NT$ -19.78NT$ -9.14NT$ -17.10NT$ -17.10
Diluted EPSNT$ -31.22NT$ -19.78NT$ -9.14NT$ -17.10NT$ -17.10
Weighted Average Shares Outstanding65.75M116.79M114.53M111.06M100.48M
Weighted Average Shares Outstanding (Diluted)65.75M116.79M114.53M111.06M100.48M

Currency in TWD

OBI Pharma, Inc. Earnings and Revenue History

-3B-1.5B01.5B-450000 %-300000 %-150000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin